End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,370 KRW | -1.52% | +0.68% | +16.91% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Service
45.6
%
| - | - | 603 | 45.6 % | - |
Hemostatic Agent
33.5
%
| 345 | 93.2 % | 444 | 33.5 % | +28.70% |
Catheter
19.9
%
| 25 | 6.8 % | 263 | 19.9 % | +946.40% |
Non-implantable Vascular Access Devices (Grade 2)
1.0
%
| - | - | 13 | 1.0 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
89.9
%
| 209 | 56.5 % | 1,189 | 89.9 % | +468.83% |
United States
7.9
%
| 99 | 26.7 % | 104 | 7.9 % | +5.31% |
Hong Kong
1.7
%
| 14 | 3.8 % | 22 | 1.7 % | +58.26% |
Greece
0.4
%
| 10 | 2.6 % | 6 | 0.4 % | -41.41% |
Japan
0.1
%
| 3 | 0.9 % | 2 | 0.1 % | -50.70% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Moon-Soo Lee
FOU | Founder | 50 | 10-04-18 |
In-Geun Mun
DFI | Director of Finance/CFO | 57 | - |
Hong-Gi Kim
CTO | Chief Tech/Sci/R&D Officer | 48 | - |
Taek-Soo Kang
AUD | Comptroller/Controller/Auditor | 64 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
In-Geun Mun
DFI | Director of Finance/CFO | 57 | - |
Moon-Soo Lee
FOU | Founder | 50 | 10-04-18 |
Hong-Gi Kim
CTO | Chief Tech/Sci/R&D Officer | 48 | - |
Jong-Man Kim
BRD | Director/Board Member | 52 | 20-03-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,236,830 | 3,823,863 ( 52.84 %) | 0 | 52.84 % |
Stock B | 0 | 42,149 | 0 | 0 |
Company contact information
InnoTherapy, Inc.
Unit 1206-1210, ACE Hitech City 2 25 Seonyu-ro 13-gil
07282, Seoul
+
http://www.innotherapy.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+16.91% | 54.58M | |
-2.17% | 89.87B | |
-3.95% | 37.57B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B | |
-18.71% | 7.32B |
- Stock Market
- Equities
- A246960 Stock
- Company SCL Science Inc.